Pfizer to seek vaccine approval in November


Russian Ambassador to Indonesia Lyudmila Vorobieva said her government had contacted the Health Ministry about the possible distribution and use of the Sputnik V vaccine and was now waiting for its response.

Without further data on how effective the vaccine is and how long immunity from it may last, it's also hard to know what impact any of the shots now in phase III trials will have on controlling the pandemic.

USA pharmaceutical giant Pfizer expects to file for emergency use authorization for its Covid-19 vaccine in late November, around two weeks after the November 3 USA presidential election, it said Friday.

They aim to be in a position to deliver tens of millions of doses to the USA by the end of the year.

Russian health authorities approved a Covid-19 vaccine created by a former biological weapons research laboratory for public use, marking the second time the Kremlin has bypassed accepted scientific protocol as it tries to field a defence against the pandemic. The agency will consider an emergency use authorization (EUA) once that data is collected from at least half of the trial's participants. AstraZeneca could provide a look at late-stage data in November.

Bourla said the filing depended on several other factors, including initial data on effectiveness that may or may not be available by late October. "If earlier, it is better", Maduro said.

Regulators for Europe and Canada are considering data on a rolling basis, as it becomes available. Who Will be The First to be Cured of Coronavirus in India?

Yes, although China and Russian Federation are on a similar timeline.

The move by China National Biotec Group Co (CNBG) is aimed at boosting public confidence in homegrown inoculations, the Journal reported, citing a company website and some students who applied for it. Johnson & Johnson ordered a temporary halt in its late-stage trial this week after a patient became ill, while AstraZeneca has paused testing in the United States since early September after a patient came down with unexplained neurological symptoms. Russian Federation has also given the vaccine to at least hundreds of "high-risk" members of the general population. "The plan includes strategies to ensure these groups are successfully vaccinated", according to a news release by the Maine Department of Health and Human Services.

That's a clear shift from Bourla's previous comments, which constantly featured "October" as the key word-at a time when President Donald Trump was touting a vaccine before the November 3 election, and mentioning Pfizer by name. The Trump administration can hire and fire HHS officials, opening the possibility of political pressure to approve a vaccine.